UKRI Developmental pathway funding scheme:
Apply for funding to develop and test novel therapeutics, medical devices, diagnostics and other interventions.

You must be based at a research organisation eligible for Medical Research Council (MRC) funding.
Your project can start and finish at any stage on the developmental pathway from early development, through pre-clinical refinement and testing to early-phase clinical studies and trials (up to phase 2a).
There is no limit on the amount of funding you can apply for, but it should be appropriate to the project. We usually fund 80% of a project’s full economic cost.

You can apply for funding for work on novel:

• candidate therapeutic entities (for example, drug discovery)
• vaccines for infectious or non-infectious disease
• biologics (antibodies, peptides, proteins)
• advanced therapeutics (for example, gene therapy and T-cell therapy)
• regenerative medicine approaches
• repurposing clinical studies or using existing therapies for new indications
• medical devices
• digital healthcare, app development or artificial intelligence
• diagnostics (including biomarker validation)
• medical imaging technology
• surgical techniques or tools
• behavioural and psychological interventions
• radiotherapy and radiation protocols
• interventions that benefit health in low and middle-income countries